ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 332121 | Rec_0338401 | Unnamed |
WXWXXX |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Bacillus subtilis MTCC 2763 |
40 μg/mL | MIC |
24953028 | - |
YES |
| 332122 | Rec_0338402 | R12 |
RRRRRRRRRRRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Bacillus cereus ATCC 10876 |
90-100 % | % inhibition at 20 μM |
24243601;26922474 | - |
YES |
| 332123 | Rec_0338403 | Peptide chain B in PDB 2OFQ |
PPPEPDWSNTVPVNKTIPVDTQ |
not reported [other] |
Protein-binding, Peptide-protein interaction, Structural binding |
PDB 2OFQ receptor chain A |
- | Protein-peptide complex structure |
- | - |
YES |
| 332124 | Rec_0338404 | Peptide chain P in PDB 3M61 |
CSARGLENHRMC |
not reported [other] |
Protein-binding, Peptide-protein interaction, Structural binding |
PDB 3M61 receptor chain U |
- | Protein-peptide complex structure |
- | - |
YES |
| 332125 | Rec_0338405 | Unnamed |
FMPIIGRLMSGSL |
not reported [other] |
Anticancer |
- |
- | - |
- | - |
NO |
| 332126 | Rec_0338406 | Lysozyme (EC 3.2.1.17) |
MNKPLRGAALAAALAGLVALEGSETTAYRDIAGVPTICSGTTAGVKMGDKATPEQCYQMTLKDYQRFERIVLDAIKVPLNVNEQTALTFFCYNVGPVCTTSTAFKRFNQGRATEGCQALAMWNKVTINGQKVVSKGLVNRRNAEIKQCLEPSSQYSSLLW |
Pseudomonas phage phiNFS [Virus] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Cytolytic, Non-hemolytic |
- |
- | - |
- | - |
NO |
| 332127 | Rec_0338407 | Lysozyme C (107-115)[A2R] |
RRWVAWRNR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus aureus ATCC 29213 |
96 μM | MIC |
20582913 | - |
YES |
| 332128 | Rec_0338408 | Unnamed |
VTDFY |
not reported [other] |
Immunomodulatory |
- |
- | - |
- | - |
NO |
| 332129 | Rec_0338409 | HR2P-M2 |
SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL |
Middle East respiratory syndrome-related coronavirus isolate United Kingdom,H123990006,2012 [Virus] |
Antiviral |
Middle East respiratory syndrome-related coronavirus isolate United Kingdom/H123990006/2012 wild-type |
0.574 μM | IC50 |
30621343 | - |
YES |
| 332130 | Rec_0338410 | H/V-peptide (12-28) |
KVANTVQKLKRKAKNAV |
synthetic construct [Synthetic] |
Hemolytic |
human erythrocytes |
0.88 % | Hemolysis |
23403131 | - |
YES |
| 332131 | Rec_0338411 | cVT18-CAKKLV (VT18 peptide derivative) |
VYPFCWGGAYAFCKAKLV |
Synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-positive,Cytotoxic |
- |
- | - |
29277569 | - |
YES |
| 332132 | Rec_0338412 | 8 |
YX |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
HeLa |
10;8.2;36.1 % | MTT assay |
16722632 | - |
YES |
| 332133 | Rec_0338413 | FRG domain-containing protein |
MPIKTTNLSYEEFYNKLFSLLRLVEGIRTKIYADSADDPKITIGIGFNIDEDKWRNVILMYKAGILQYTDLENGVYTLANILGKQSQSMQILINTTSKEIKDKINEYKASNKIQKNTYQTGKNPNQNMINLQKDINAILQNNIKIYNQNLENINQKLDENIVFELTDNEAIEVKNIISFSEIRALRHKLNKWNANYLTSFSKTELTNPQEFIPLLSIYYQSPTRIKGLDNSNSIKDLILLQKALKDKNRFLAWFSVRYYADICRYNVQKKTNPYYSRRIQEAAMFGLSNKNQNNNIEYFSTSLDIFSYLNFNFREANAKQGLKLPDKYTYLSFMQTYDKCKEVDEKAEYLLREYNTYHTKDKHYYSYVAKEEFQGIADILSPYLSYLNTLTQKNFSLDNIYCIANYCENLGANKLDNVALLNKTLRQKFEKLEANTPHNILILYPNPTPSIIQIEQPKNTFITLLIGAKAKIDCSKLIEDQCELMYLKYDPTQEEQQAINPQAFSCSTQEELILKKEDEIYFKTVKNNISYFINKNDGILKVALTGNEENAIELYSFAKENQFKILQDKASKMLKIYLKLERYSSEEILSHRGGNFELTLNNLKILDKNGNNHETITKIFLHNCENRRIYESLKLEYQEGIYKSSFKIDLILDENSSFFKRATKCIIATKTLEGFSTSQMHKIGNVAIVSLSSADKQGGCYTFTNKVSMQDFGENLYLDTETNGYEKQIKNSRENLYITNLKAYKEKEQQNTTDKIPYNETIFVRAYLNNEEKFFFDETIKWAYCVKKEEELECNQSKIKILENLQGNDIAFNTSMLSQNDRNILYNMNEKYQLILFAYFNTPAFKTTQGITHLVLK |
Campylobacter jejuni [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 332134 | Rec_0338414 | SH3 domain protein |
MKKQKLFVRIVCIALVVLMAVSVGAVAITAFSANAAQSTEEVSASVSAGASGYINASYVNLRSGAGTNYSVITCMAKNTKFTFVDGKLYNSKWYKIKLKSNSKTGYVTKEYVAVSSSTTASSVTGYVSDDYVNLRSGAGTNYSVVGCLRKNTKLTFVSTSLYNSAWYKVKVTSTAKTGYIKKDYVKMNSSTQPATKATQPTTKATKPVTQPTASASTVSGYITDDYVNLRSGAGTSYSVVECMRVNTKVIFVSTKLYNNDWYNIKLTSNSKTGYVKKDYVKMNSQTQPTTTRPTTTKPSTGSSVKLSVSSKSIFTGNRFAITATASGSVSWSSSNTGVATVDSRGIVTAKKAGSATITAKSGSHSATCKITVKSGSSVNISNSNVNLPWQKSMLLKSRTSGVTWSSSNTKIATVKNGVVDTVGKGYVTITASTSYGAATCLIHVMPRESVRFCYASPNSAPLNSNVSFKAITDTGRVGVYFVVTNGSTSYKVTATSKVKDGNSYIWTGTQKLSKSGKWSVKAYSKFKAESKYYTTAGGGEGEVFVTSTTNKTTTACAERRASDEVIKLIANYEGFLSKVTADSITTDPTLGYGKVVISGEQFYNNITSNQAYAYLCQTVNKGGYTTTTNSYLVNNGIKFNQRQFDALVCFAYNVGSGVFYNDSELQSVLLNTGSSGTIKAGASGTVTGSDVNLRRGAGTNYSVVTRMNYGTKLKFVDGKRYNTNWYKVKLSNGTTGYIHKDYVSASGGSRDLNNVNKQNLIDALLQYHHAAGSCYWGLLYRRVDEAETFLYGDYDRDGQHNYHHFHFSCYSNPSFGI |
Ruminococcus sp. CAG:108 [Bacterium] |
Antimicrobial, Bacteriolytic, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 332135 | Rec_0338415 | Lysozyme (EC 3.2.1.17) |
MSLKQKIAALTTAGATAIALVVIAHFEGVRYEPYRDVAGILTVCYGHTGKDIIHGKTYTQQECDALLQNDFIKTQQQVDALIKVPLDDYIKAALYSFAFNVGMTAFARSTLLKKLNAGDRAGACEEIKRWVYAGGKGFGEGLSVVEKRSQHYVMETFNHHYQLYPCITHHSRWWYLSLD |
Proteus mirabilis [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | - |
- | - |
NO |
| 332136 | Rec_0338416 | Hydramacin-1 (Hm-1; annelida, animals) |
QIVDCWETWSRCTKWSQGGTGTLWKSCNDRCKELGRKRGQCEEKPSRCPLSKKAWTCICY |
Hydra vulgaris [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
freundii C7 |
0.9 μM | MBC |
19013190;19019828 | - |
YES |
| 332137 | Rec_0338417 | Unnamed |
WSKVVL |
not reported [other] |
Antihypertensive,ACE inhibitory |
ACE |
154.88 μM | IC50 |
23194537 | - |
YES |
| 332138 | Rec_0338418 | opt2 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A) |
VRLRIRVRVIRK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Antifungal |
Staphylococcus epidermidis |
0.8 μg/mL | MIC |
17052614 | - |
YES |
| 332139 | Rec_0338419 | Unnamed |
YNKL |
Undaria pinnatifida [Protist] |
Antihypertensive |
Spontaneously hypertensive rat (SHR) |
50 mmHg | SBP decrease |
23271625 | - |
NO |
| 332140 | Rec_0338420 | SADPNFLRF-amide |
SADPNFLRF |
Caenorhabditis elegans [Animal] |
Neuropeptide, Neuromodulator, Myotropic, Receptor modulation |
- |
- | - |
16061202 | - |
YES |